The maternal immune activation model uncovers a role for the Arx gene in GABAergic dysfunction in schizophrenia

Autor: Nakamura, Jay P., Schroeder, Anna, Hudson, Matthew, Jones, Nigel, Gillespie, Brendan, Du, Xin, Notaras, Michael, Swaminathan, Vaidy, Reay, William R., Atkins, Joshua R., Green, Melissa J., Carr, Vaughan J., Cairns, Murray J., Sundram, Suresh, Hill, Rachel A.

Publikováno v: In Brain Behavior and Immunity October 2019 81:161-171

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

4:45 PM PREMORBID AND CURRENT COGNITIVE FUNCTION IN SCHIZOPHRENIA ASSOCIATE WITH TREATMENT RESISTANCE AND EGF 61 AA GENOTYPE

Autor: Swaminathan, Vaidy, Pereira, Avril M., Shannon-Weickert, Cynthia, Weickert, Thomas, Sundram, Suresh

Publikováno v: In Schizophrenia Research April 2014 153 Supplement 1:S57-S57

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The impact of premorbid and current intellect in schizophrenia: cognitive, symptom, and functional outcomes.

Autor: Wells R; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia; Neuroscience Research Australia, Randwick, Sydney, NSW, Australia., Swaminathan V; Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia; Northern Psychiatry Research Centre, North Western Mental Health, Melbourne Health, Victoria, Australia; Schizophrenia Research Institute, Sydney, NSW, Australia; Molecular Psychopharmacology Laboratory, The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia., Sundram S; Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia; Northern Psychiatry Research Centre, North Western Mental Health, Melbourne Health, Victoria, Australia; Molecular Psychopharmacology Laboratory, The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia., Weinberg D; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia; Neuroscience Research Australia, Randwick, Sydney, NSW, Australia., Bruggemann J; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia; Neuroscience Research Australia, Randwick, Sydney, NSW, Australia., Jacomb I; Neuroscience Research Australia, Randwick , Sydney, NSW, Australia., Cropley V; Department of Psychiatry, University of Melbourne , Parkville, VIC, Australia., Lenroot R; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia; Neuroscience Research Australia, Randwick, Sydney, NSW, Australia; Schizophrenia Research Institute, Sydney, NSW, Australia., Pereira AM; Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia; Molecular Psychopharmacology Laboratory, The Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia., Zalesky A; Department of Psychiatry, University of Melbourne , Parkville, VIC, Australia., Bousman C; Department of Psychiatry, University of Melbourne , Parkville, VIC, Australia., Pantelis C; Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia; Schizophrenia Research Institute, Sydney, NSW, Australia., Weickert CS; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia; Neuroscience Research Australia, Randwick, Sydney, NSW, Australia; Schizophrenia Research Institute, Sydney, NSW, Australia., Weickert TW; School of Psychiatry, University of New South Wales, Sydney, NSW, Australia; Neuroscience Research Australia, Randwick, Sydney, NSW, Australia; Schizophrenia Research Institute, Sydney, NSW, Australia.

Publikováno v: NPJ schizophrenia [NPJ Schizophr] 2015 Nov 04; Vol. 1, pp. 15043. Date of Electronic Publication: 2015 Nov 04 (Print Publication: 2015).